Raptor Pharmaceuticals Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 182

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

  • Investments
  • 7

Raptor Pharmaceuticals General Information

Description

Provider of bio-pharmaceutical therapies intended to treat diseases that are debilitating and life-threatening. The company's bio-pharmaceutical therapies focuses on developing and commercializing therapies to treat debilitating and often fatal diseases for Huntington's disease, non-fatty liver disease, primary liver cancer & other cancers.

Contact Information

Formerly Known As
Raptor Therapeutics, Raptor Pharmaceutical Corp
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 7 Hamilton Landing
  • Suite 100
  • Novato, CA 94949
  • United States
+1 (415) 000-0000
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 7 Hamilton Landing
  • Suite 100
  • Novato, CA 94949
  • United States
+1 (415) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Raptor Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Raptor Pharmaceuticals‘s full profile, request access.

Request a free trial

Raptor Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of bio-pharmaceutical therapies intended to treat diseases that are debilitating and life-threatening. The comp
Pharmaceuticals
Novato, CA
182 As of 2016
000.00
00000 0000-00-00
000000&0 000.00

00000

tion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure do
000000000000000
Rahway, NJ
00000 As of 0000
0000
000000000 - 0000

000000

t, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
000000000000000
Tokyo, Japan
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Raptor Pharmaceuticals Competitors (133)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merck & Co. Corporation Rahway, NJ 00000 0000 000000000 - 0000
Astellas Pharma Corporation Tokyo, Japan 00000 00000000
Amylyx Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
XBiotech Corporation Austin, TX 00 0000 00000000 0000
Ironwood Pharmaceuticals Formerly VC-backed Boston, MA 000 00000 000000000 00000
You’re viewing 5 of 133 competitors. Get the full list »

Raptor Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Raptor Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Raptor Pharmaceuticals‘s full profile, request access.

Request a free trial

Raptor Pharmaceuticals Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Quinsair 05-Oct-2015 0000000000 00000 Pharmaceuticals 00000 000
TorreyPines Therapeutics 28-Sep-2009 0000000000 Biotechnology 000 00000
Convivia (ALDH2 deficiency product) 21-Apr-2008 0000000000 Buildings and Property
University of California, San Diego (worldwide license to intellectual property of Cysteamine) 19-Mar-2008 000000000 Buildings and Property
CalciMedica 23-Jan-2008 Early Stage VC 00.000 Drug Discovery
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Raptor Pharmaceuticals FAQs

  • Who is the founder of Raptor Pharmaceuticals?

    Todd Zankel is the founder of Raptor Pharmaceuticals.

  • Where is Raptor Pharmaceuticals headquartered?

    Raptor Pharmaceuticals is headquartered in Novato, CA.

  • What is the size of Raptor Pharmaceuticals?

    Raptor Pharmaceuticals has 182 total employees.

  • What industry is Raptor Pharmaceuticals in?

    Raptor Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Raptor Pharmaceuticals a private or public company?

    Raptor Pharmaceuticals is a Private company.

  • What is the current valuation of Raptor Pharmaceuticals?

    The current valuation of Raptor Pharmaceuticals is 00000.

  • What is Raptor Pharmaceuticals’s current revenue?

    The current revenue for Raptor Pharmaceuticals is 000000.

  • How much funding has Raptor Pharmaceuticals raised over time?

    Raptor Pharmaceuticals has raised $17.1M.

  • Who are Raptor Pharmaceuticals’s investors?

    Great Point Partners, Heights Capital Management, Patricia Industries, RiverVest Venture Partners, and Synthesis Capital (Boston) have invested in Raptor Pharmaceuticals.

  • Who are Raptor Pharmaceuticals’s competitors?

    Merck & Co., Astellas Pharma, Amylyx, XBiotech, and Ironwood Pharmaceuticals are some of the 133 competitors of Raptor Pharmaceuticals.

  • When was Raptor Pharmaceuticals acquired?

    Raptor Pharmaceuticals was acquired on 25-Oct-2016.

  • Who acquired Raptor Pharmaceuticals?

    Raptor Pharmaceuticals was acquired by Horizon Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »